ASSERTIO THERAPEUTICS, INC. Cash and Cash Equivalents
ASSERTIO THERAPEUTICS, INC. had Cash and Cash Equivalents of $22.53 million as of 2020-12-31, per its 10-Q filed 2011-08-02.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2020-05-11
- 2020-12-31: Cash and Cash Equivalents, at Carrying Value $22.53M.
- 2020-03-31: Cash and Cash Equivalents, at Carrying Value $105.97M.
- 2019-12-31: Cash and Cash Equivalents, at Carrying Value $42.11M.
- 2019-09-30: Cash and Cash Equivalents, at Carrying Value $54.18M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2020-12-31 | $22.53M 10-Q · filed 2011-08-02 |
| 2020-03-31 | $105.97M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $42.11M 10-Q · filed 2020-05-11 |
| 2019-09-30 | $54.18M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $68.35M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $109.69M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $110.95M 10-K · filed 2020-03-10 |
| 2018-09-30 | $121.90M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $57.23M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $101.69M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $126.88M 10-K · filed 2019-03-11 |
| 2017-09-30 | $107.58M 10-Q · filed 2018-11-09 |
| 2017-06-30 | $113.22M 10-Q · filed 2018-08-08 |
| 2017-03-31 | $187.81M 10-Q · filed 2018-05-10 |
| 2016-12-31 | $117.71M 10-K · filed 2019-03-11 |
| 2016-09-30 | $90.36M 10-Q · filed 2017-11-09 |
| 2016-06-30 | $87.82M 10-Q · filed 2017-08-07 |
| 2016-03-31 | $181.97M 10-Q · filed 2017-05-10 |
| 2015-12-31 | $101.08M 10-K · filed 2019-03-11 |
| 2015-09-30 | $107.50M 10-Q · filed 2016-11-07 |
| 2015-06-30 | $94.09M 10-Q · filed 2016-08-03 |
| 2015-03-31 | $52.78M 10-Q · filed 2016-05-06 |
| 2014-12-31 | $488.67M 10-K · filed 2018-03-01 |
| 2014-09-30 | $546.70M 10-Q · filed 2015-11-09 |
| 2014-06-30 | $211.15M 10-Q · filed 2015-08-03 |
| 2014-03-31 | $195.29M 10-Q · filed 2015-05-11 |
| 2013-12-31 | $244.67M 10-K · filed 2017-02-24 |
| 2013-09-30 | $64.28M 10-Q · filed 2014-11-06 |
| 2013-06-30 | $44.93M 10-Q · filed 2014-08-06 |
| 2013-03-31 | $21.93M 10-Q · filed 2014-05-09 |
| 2012-12-31 | $29.08M 10-K · filed 2016-02-26 |
| 2012-09-30 | $27.37M 10-Q · filed 2013-11-07 |
| 2012-06-30 | $13.52M 10-Q · filed 2013-08-08 |
| 2012-03-31 | $40.21M 10-Q · filed 2013-05-09 |
| 2011-12-31 | $24.04M 10-K · filed 2015-02-26 |
| 2011-09-30 | $19.95M 10-Q · filed 2012-11-05 |
| 2011-06-30 | $36.31M 10-Q/A · filed 2012-08-13 |
| 2011-03-31 | $83.85M 10-Q · filed 2012-05-08 |
| 2010-12-31 | $22.53M 10-K · filed 2014-03-17 |
| 2010-09-30 | $20.23M 10-Q · filed 2011-11-07 |
| 2010-06-30 | $22.25M 10-Q · filed 2011-08-02 |
| 2009-12-31 | $26.82M 10-K · filed 2013-02-22 |
| 2008-12-31 | $22.13M 10-K · filed 2012-03-08 |